ARUP Laboratories Launches Spectral Flow Cytometry Assay for Enhanced Multiple Myeloma Testing
Diagnostic reference facility launches clinical testing suite featuring advanced spectral flow cytometry to improve minimal residual disease profiling for cancer patients. News About Spectral Flow Cytometry ARUP Laboratories announced the official release of its clinical assay titled ARUP CLARISPECT Multiple Myeloma MRD by Spectral Flow Cytometry. The diagnostic product deployment marks ARUP as the first…